In addition to its association with hyperglycemic conditions, dysregulation of MEG3 expression has been implicated in the pathogenesis of various cardio-cerebrovascular and neurodegenerative diseases, largely through its involvement in apoptosis, inflammation, and oxidative stress pathways 38. This evidence concerns the gene MEG3 and neurodegenerative disease.